Page last updated: 2024-09-03

rc 3095 and bim 23127

rc 3095 has been researched along with bim 23127 in 1 studies

Compound Research Comparison

Studies
(rc 3095)
Trials
(rc 3095)
Recent Studies (post-2010)
(rc 3095)
Studies
(bim 23127)
Trials
(bim 23127)
Recent Studies (post-2010) (bim 23127)
1082261504

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunetto, AL; Brunetto, AT; de Farias, CB; Fratini, L; Ghisleni, EC; Gregianin, LJ; Jaeger, M; Roesler, R; Schwartsmann, G1

Other Studies

1 other study(ies) available for rc 3095 and bim 23127

ArticleYear
Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2016, Volume: 32, Issue:1

    Topics: Analysis of Variance; Antineoplastic Agents; Apoptosis; Bombesin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; Peptide Fragments; Peptides, Cyclic; Receptors, Bombesin

2016